Results 31 to 40 of about 192,096 (187)

Metabolite Profiling of the Antisense Oligonucleotide Eluforsen Using Liquid Chromatography-Mass Spectrometry

open access: yesMolecular Therapy: Nucleic Acids, 2019
Eluforsen (previously known as QR-010) is a 33-mer 2′-O-methyl modified phosphorothioate antisense oligonucleotide targeting the F508del mutation in the gene encoding CFTR protein of cystic fibrosis patients.
Jaeah Kim   +6 more
doaj   +1 more source

Challenges and future perspective of antisense therapy for spinal muscular atrophy: A review

open access: yesEuropean Journal of Cell Biology, 2023
Spinal muscular atrophy (SMA), the most common genetic cause of infantile death, is caused by a mutation in the survival of motor neuron 1 gene (SMN1), leading to the death of motor neurons and progressive muscle weakness.
Zorica Nakevska, Toshifumi Yokota
doaj   +1 more source

Primers used for RT-PCR. S, sense oligonucleotide; AS, antisense oligonucleotide.

open access: yes, 2013
Primers used for RT-PCR. S, sense oligonucleotide; AS, antisense oligonucleotide.
Andrea-Kaye Datu (584123)   +1 more
core   +1 more source

Evidence for a Specific Intracellular Localization of an Antisense Oligonucleotide in K562 Cells

open access: yesJournal of Pharmacological Sciences, 2005
In order to be active, antisense oligonucleotides (ASOs) should be delivered to the nuclei of cells. The lack of effect of some ASOs might be explained by poor distribution inside the cell.
M. Helena Vasconcelos   +4 more
doaj   +1 more source

Oligonucleotide Mimics for Antisense Therapeutics:  Solution Phase and Automated Solid-Support Synthesis of MMI Linked Oligomers

open access: yes, 2016
Oligonucleotide Mimics for Antisense Therapeutics:  Solution Phase and Automated Solid-Support Synthesis of MMI Linked ...
Michel Perbost (2995368)   +4 more
core   +2 more sources

Polymerase-endonuclease amplification reaction for large-scale enzymatic production of antisense oligonucleotide [PDF]

open access: yes, 2009
Synthetic oligonucleotides are contaminated with highly homologous failure sequences. Oligonucleotide synthesis is difficult to scale up because it requires expensive equipments, hazardous chemicals, and tedious purification process.
Deming Gou, Xiaolong Wang
core  

Silencing disease genes in the laboratory and the clinic

open access: yes, 2011
Synthetic nucleic acids are commonly used laboratory tools for modulating gene expression and have the potential to be widely used in the clinic. Progress towards nucleic acid drugs, however, has been slow and many challenges remain to be overcome before
Jonathan K Watts   +3 more
core   +1 more source

WO 2014203008 A1 Antisense oligonucleotide compositions

open access: yes, 2014
The present invention relates to antisense oligonucleotide (ASO) compositions and particularly to compositions and methods for the cytosolic delivery of antisense oligonucleotides (ASOs).
Mitchell, John   +2 more
core   +5 more sources

Rethinking antisense oligonucleotide therapeutics for amyotrophic lateral sclerosis

open access: yesAnnals of Clinical and Translational Neurology
Antisense oligonucleotides, which are used to silence target genes, are gaining attention as a novel drug discovery modality for proteinopathies. However, while clinical trials for neurodegenerative diseases like amyotrophic lateral sclerosis have been ...
Daisuke Ito, Kensuke Okada
doaj   +1 more source

Potential antisense oligonucleotide targeting LINC00673 on proliferation and apoptosis in tongue squamous cell carcinoma

open access: yesJournal of Taibah University Medical Sciences
الملخص: أهداف البحث: تزداد معدلات الإصابة بسرطان اللسان، المعروف بطبيعته العدوانية، سنويًّا في إندونيسيا وعلى مستوى العالم. ويرتبط أحد العوامل الجزيئية المرتبطة بسرطان اللسان البشري بارتفاع التعبير عن الحمض النووي الريبوزي الطويل غير المشفِّر (LINC٠٠٦٧٣)
Kadek Gede Putra Wibawa, DDS   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy